Inventor · disambiguated record
Richard J. Bucala
Also filed as: BUCALA RICHARD · BUCALA RICHARD J
57 granted patents·27 pending applications·1,991 citations·filing 1992–2020
99Inventor score
Files withPICOWER INST MED RES28BUCALA RICHARD J9UNIV YALE8CYTOKINE PHARMASCIENCES INC6UNIV ROCKEFELLER6
Top patents by PatentIndex Score
84 records- 0198US6030615ACombination method for treating diseases caused by cytokine-mediated toxicityPICOWER INST MED RES·Filed 1995·Granted Feb 29, 2000·136 cites·3 claims
- 0297US10202343B2MIF modulatorsUNIV YALE·Filed 2017·Granted Feb 12, 2019·35 cites·3 claims
- 0397US5654186ABlood-borne mesenchymal cellsPICOWER INST MED RES·Filed 1993·Granted Aug 5, 1997·176 cites·15 claims
- 0495US9540322B2MIF modulatorsJORGENSEN WILLIAM L·Filed 2011·Granted Jan 10, 2017·38 cites·29 claims
- 0595US5935927ACompositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproductsPICOWER INST MED RES·Filed 1995·Granted Aug 10, 1999·153 cites·9 claims
- 0694US9643922B2MIF modulatorsJORGENSEN WILLIAM L·Filed 2010·Granted May 9, 2017·40 cites·32 claims
- 0793US6080407ADiagnostic assays for MIFPICOWER INST MED RES·Filed 1995·Granted Jun 27, 2000·72 cites·18 claims
- 0892US5846796ABlood-borne mesenchymal cellsPICOWER INST MED RES·Filed 1995·Granted Dec 8, 1998·91 cites·2 claims
- 0991US6645493B1Composition containing anti-MIF antibodyPICOWER INST MED RES·Filed 1995·Granted Nov 11, 2003·55 cites·9 claims
- 1090US5869534AGlycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefromPICOWER INST MED RES·Filed 1993·Granted Feb 9, 1999·68 cites·13 claims
- 1190US5733546AImmunochemical detection of in vivo advanced glycosylation endproductsUNIV ROCKEFELLER·Filed 1995·Granted Mar 31, 1998·49 cites·20 claims
- 1290US5683887AImmunochemical detection of in vivo advanced glycosylation endproductsUNIV ROCKEFELLER·Filed 1995·Granted Nov 4, 1997·51 cites·16 claims
- 1389US5780615AGlycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefromPICOWER INST MED RES·Filed 1995·Granted Jul 14, 1998·70 cites·10 claims
- 1489US5700447AMethods and materials for the diagnosis and treatment of conditions such as strokePICOWER INST MED RES·Filed 1994·Granted Dec 23, 1997·76 cites·8 claims
- 1588US5702704AAntibodies to in vivo advanced glycosylation endproductsUNIV ROCKEFELLER·Filed 1995·Granted Dec 30, 1997·56 cites·15 claims
- 1687US7517523B2Anti-MIF antibodiesCYTOKINE PHARMASCIENCES INC·Filed 2003·Granted Apr 14, 2009·8 cites·17 claims
- 1786US6413939B1Inducible phosphofructokinase and the Warburg effectPICOWER INST MED RES·Filed 1997·Granted Jul 2, 2002·48 cites·10 claims
- 1886US6174526B1Blood-borne mesenchymal cellsPICOWER INST MED RES·Filed 1995·Granted Jan 16, 2001·58 cites·8 claims
- 1985US6492428B1Compounds having MIF antagonist activityPICOWER INST MED RES·Filed 2000·Granted Dec 10, 2002·23 cites·11 claims
- 2085US6380165B1Immunological advanced glycation endproduct crosslinkPICOWER INST MED RES·Filed 1997·Granted Apr 30, 2002·68 cites·3 claims
- 2185US5733524AMethods and materials for the diagnosis and treatment of conditions such as strokePICOWER INST MED RES·Filed 1995·Granted Mar 31, 1998·72 cites·3 claims
- 2284US5801200AMethods and materials for the diagnosis and treatment of conditions such as strokePICOWER INST MED RES·Filed 1995·Granted Sep 1, 1998·68 cites·3 claims
- 2384US5733933AMethods and materials for the diagnosis and treatment of conditions such as strokePICOWER INST MED RES·Filed 1995·Granted Mar 31, 1998·65 cites·2 claims
- 2481US8617822B2Method of inhibiting binding or activity of MIF by administering a MIF antagonistBUCALA RICHARD J·Filed 2010·Granted Dec 31, 2013·4 cites·5 claims
- 2581US5804446ABlood-borne mesenchymal cellsPICOWER INST MED RES·Filed 1995·Granted Sep 8, 1998·55 cites·7 claims
- 2680US6599938B1Compounds having MIF antagonist activityPICOWER INST OF MEDICAL RES·Filed 2000·Granted Jul 29, 2003·19 cites·15 claims
- 2780US6420188B1Screening assay for the identification of inhibitors for macrophage migration inhibitory factorPICOWER INST MED RES·Filed 1996·Granted Jul 16, 2002·54 cites·3 claims
- 2879US6054121AModulation of immune responses in blood-borne mesenchymal cellsPICOWER INST MED RES·Filed 1995·Granted Apr 25, 2000·52 cites·4 claims
- 2976US10842859B2Uses of parasite macrophage migration inhibitory factorsUNIV YALE·Filed 2015·Granted Nov 24, 2020·1 cites·8 claims
- 3076US7741057B2Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factorCYTOKINE PHARMASCIENCES INC·Filed 2007·Granted Jun 22, 2010·1 cites·4 claims
- 3175US6774227B1Therapeutic uses of factors which inhibit or neutralize MIF activityCYTOKINE PHARMASCIENCES INC·Filed 1996·Granted Aug 10, 2004·19 cites·1 claims
- 3275US6410598B1Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosisFiled 1995·Granted Jun 25, 2002·47 cites·5 claims
- 3374US9221903B2Method of inhibiting binding or activity of MIF by administering a MIF antagonistBAXTER INT·Filed 2013·Granted Dec 29, 2015·1 cites·8 claims
- 3473US5849307AVaccine adjuvantPICOWER INST MED RES·Filed 1997·Granted Dec 15, 1998·38 cites·8 claims
- 3572US8779099B2MIF antagonistsBUCALA RICHARD J·Filed 2011·Granted Jul 15, 2014·1 cites·2 claims
- 3672US2010184091A1Method for determining MIF contentCYTOKINE PHARMASCIENCES INC·Filed 2009·Application pending·0 cites
- 3770US11584717B2MIF modulatorsUNIV YALE·Filed 2018·Granted Feb 21, 2023·0 cites·3 claims
- 3870US2020377457A1Mif modulatorsUNIV YALE·Filed 2020·Application pending·0 cites
- 3969US6998238B2Method for determining MIF contentCYTOKINE PHARMASCIENCES INC·Filed 2000·Granted Feb 14, 2006·5 cites·10 claims
- 4069US5624804AImmunochemical detection of In vivo advanced glycosylation end productsUNIV ROCKEFELLER·Filed 1992·Granted Apr 29, 1997·16 cites·34 claims
- 4165US6596851B1Inducible phosphofructokinase and the Warburg effectPICOWER INST MED RES·Filed 2000·Granted Jul 22, 2003·1 cites·1 claims
- 4265US2015010570A1Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factorBAXTER INT·Filed 2014·Application pending·0 cites
- 4364US2009263404A1Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory FactorBUCALA RICHARD J·Filed 2008·Application pending·0 cites
- 4463US2021030859A1Uses of parasite macrophage migration inhibitory factorsUNIV YALE·Filed 2020·Application pending·0 cites
- 4562US7205107B2Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory diseaseCYTOKINE PHARMASCIENCES INC·Filed 2002·Granted Apr 17, 2007·3 cites·3 claims
- 4662US2012149044A1Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicityBUCALA RICHARD J·Filed 2012·Application pending·0 cites
- 4762US2018105593A1Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factorBAXALTA INC·Filed 2016·Application pending·0 cites
- 4860US2016152708A1Method of inhibiting binding or activity of mif by administering a mif antagonistBAXALTA INC·Filed 2015·Application pending·0 cites
- 4959US6110968AMethods for treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproductsPICOWER INST MED RES·Filed 1998·Granted Aug 29, 2000·20 cites·9 claims
- 5059US2008089884A1Compositions and methods for the modulation of detrusor activityKUCHEL GEORGE A·Filed 2007·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →